| RS573586959 |
NDUFS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS57358989 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1C, localized |
| RS573597311 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS573598298 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS573603750 |
SPRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Legius syndrome, Cardiovascular phenotype |
| RS573607437 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, PCCA-related disorder |
| RS573617450 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Inborn genetic diseases |
| RS573621071 |
COG4
|
Health Risk |
Conflicting classifications of pathogenicity |
COG4-congenital disorder of glycosylation, Inborn genetic diseases |
| RS573622329 |
ASTN2;TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcotubular myopathy, Bardet-Biedl syndrome 11 |
| RS573629753 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Autoinflammatory syndrome |
| RS573642949 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, SPAST-related disorder |
| RS57364972 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS573649990 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Centronuclear myopathy |
| RS573662782 |
PPP2R5D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS573670976 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS573684358 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS573691331 |
SLC25A22
|
Health Risk |
Likely pathogenic |
— |
| RS573693040 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS573695008 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS573699597 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Gonadotropin-independent familial sexual precocity, Leydig cell agenesis |
| RS573721058 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS573727689 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS573728571 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS573733606 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS573740263 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS57374291 |
PTEN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS573744591 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS573745685 |
HFE
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 1, 6 conditions |
| RS573748379 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alstrom syndrome |
| RS573750741 |
CA2
|
Health Risk |
Pathogenic |
Osteopetrosis with renal tubular acidosis, Osteopetrosis |
| RS573767517 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS573774777 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS573775230 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
WFS1-Related Spectrum Disorders, Autosomal dominant nonsyndromic hearing loss 6 |
| RS57377812 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS573779258 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS573784011 |
PSTPIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome, Pyogenic arthritis-pyoderma gangrenosum-acne syndrome |
| RS573785616 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS573792379 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS573806608 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS573808767 |
CFTR
|
Health Risk |
Likely pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, Bronchiectasis with or without elevated sweat chloride 1 |
| RS573817924 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Aplastic anemia, Pulmonary fibrosis and/or bone marrow failure |
| RS573821685 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS573825281 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS573837366 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spectraplakinopathy type I, Lissencephaly 9 with complex brainstem malformation |
| RS573839835 |
ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS573843615 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS573849874 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS573856624 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMB1-related disorder, Inborn genetic diseases |
| RS573864607 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS573873623 |
SHANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS573877174 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS573884006 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Ehlers-Danlos syndrome |
| RS573886282 |
KLHL40
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS573891636 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, Inborn genetic diseases |
| RS573892607 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD1-related dilated cardiomyopathy, Cardiovascular phenotype |
| RS573893736 |
CASP8
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS573898913 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS573899913 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS573900018 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS573904763 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS573907581 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 5, Inborn genetic diseases |
| RS573916965 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS573918155 |
TG
|
Health Risk |
Pathogenic |
— |
| RS573931575 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ZNF469-related disorder |
| RS573932867 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS573941336 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS573951598 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cardiovascular phenotype |
| RS573958749 |
WDR35
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 2, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS57396313 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS573968273 |
SLC22A12
|
Health Risk |
Conflicting classifications of pathogenicity |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS573971701 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS573971763 |
LZTR1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS573977862 |
CACNB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Idiopathic generalized epilepsy |
| RS573982253 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS573984029 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS573985690 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS573992101 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS573998309 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS574000398 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young |
| RS574007567 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS574020110 |
PTPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS574023538 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS574024586 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS574028286 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS574032499 |
BBS10
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome 10 |
| RS574033788 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS574034197 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS574039421 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS574041847 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS574050786 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS574051756 |
PKLR
|
Health Risk |
Pathogenic/Likely pathogenic |
PKLR-related disorder, PKLR-related disorder |
| RS574061789 |
APOA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS574069625 |
WNK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neuropathy |
| RS574074583 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS574086514 |
FOXK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS574087581 |
PCDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Diencephalic-mesencephalic junction dysplasia syndrome 1, Diencephalic-mesencephalic junction dysplasia syndrome 1 |
| RS574088829 |
SOS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 3, RASopathy |
| RS574098823 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS574099162 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Inborn genetic diseases |
| RS574102153 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |